Unique efficacy of Toll-like receptor 8 agonists in activating human neonatal antigen-presenting cells.

Newborns are prone to microbial infection and have poor memory responses to multiple antigens. We have previously shown that human neonatal blood monocytes exhibit impaired TNF-alpha responses to most known TLR agonists, including the pure TLR7 agonist imiquimod. Surprisingly, however, neonatal TNF-alpha responses to the imiquimod congener R-848 (TLR 7/8) were fully intact. We now show that TLR8 agonists, including R-848 (TLR7/8), the imidazoquinoline congeners 3M-003 (TLR7/8) and 3M-002 (TLR8), as well as single-stranded viral RNAs (TLR8) induced robust production of the Th1-polarizing cytokines TNF-alpha and IL-12 from neonatal antigen-presenting cells (APCs) that substantially exceeds responses induced by TLR-2, -4, or -7 (alone) agonists. TLR8 agonists also effectively induced up-regulation of the costimulatory molecule CD40 on neonatal and adult myeloid dendritic cells (DCs). The strong activity of TLR8 agonists correlates with their induction of p38 MAP kinase phosphorylation and with degradation of IkappaB-alpha in both neonatal and adult monocytes. We conclude that TLR8 agonists are uniquely efficacious in activating costimulatory responses in neonatal APCs and suggest that these agents are promising candidate adjuvants for enhancing immune responses in human newborns.

[1]  A. Fanaroff.  The Adenosine System Selectively Inhibits TLR-Mediated TNF-α Production in the Human Newborn , 2007 .

[2]  O. Levy,et al.  The Adenosine System Selectively Inhibits TLR-Mediated TNF-α Production in the Human Newborn1 , 2006, The Journal of Immunology.

[3]  L. Kalish,et al.  Innate Immunity of the Human Newborn Is Polarized Toward a High Ratio of IL-6/TNF-α Production In Vitro and In Vivo , 2006, Pediatric Research.

[4]  Mary E Dickinson,et al.  Moving Toward the Light: Using New Technology to Answer Old Questions , 2006, Pediatric Research.

[5]  E. Benveniste,et al.  LPS induces CD40 gene expression through the activation of NF-κB and STAT-1α in macrophages and microglia , 2005 .

[6]  D. Golenbock,et al.  Human cardiac inflammatory responses triggered by Coxsackie B viruses are mainly Toll‐like receptor (TLR) 8‐dependent , 2005, Cellular microbiology.

[7]  Houping Ni,et al.  Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. , 2005, Immunity.

[8]  Ross M. Kedl,et al.  Immunization with HIV-1 Gag Protein Conjugated to a TLR7/8 Agonist Results in the Generation of HIV-1 Gag-Specific Th1 and CD8+ T Cell Responses , 2005, The Journal of Immunology.

[9]  J. Banchereau,et al.  Mobilization of plasmacytoid and myeloid dendritic cells to mucosal sites in children with respiratory syncytial virus and other viral respiratory infections. , 2005, The Journal of infectious diseases.

[10]  N. Bumstead,et al.  Identification and characterization of a functional, alternatively spliced Toll‐like receptor 7 (TLR7) and genomic disruption of TLR8 in chickens , 2005, Immunology.

[11]  M. Tomai,et al.  Synthetic TLR Agonists Reveal Functional Differences between Human TLR7 and TLR8 , 2005, Journal of Immunology.

[12]  O. Levy,et al.  Selective Impairment of TLR-Mediated Innate Immunity in Human Newborns: Neonatal Blood Plasma Reduces Monocyte TNF-α Induction by Bacterial Lipopeptides, Lipopolysaccharide, and Imiquimod, but Preserves the Response to R-8481 , 2004, The Journal of Immunology.

[13]  Shizuo Akira,et al.  Toll-like receptor signalling , 2004, Nature Reviews Immunology.

[14]  J. Willigen,et al.  Defective macrophage function in neonates and its impact on unresponsiveness of neonates to polysaccharide antigens , 2004, Journal of leukocyte biology.

[15]  C. Van Lint,et al.  A Defect in Nucleosome Remodeling Prevents IL-12(p35) Gene Transcription in Neonatal Dendritic Cells , 2004, The Journal of experimental medicine.

[16]  S. Quezada,et al.  CD40/CD154 interactions at the interface of tolerance and immunity. , 2004, Annual review of immunology.

[17]  Shizuo Akira,et al.  Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA , 2004, Science.

[18]  S. Akira,et al.  Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8 , 2004, Science.

[19]  A. Stadnyk,et al.  Role of MyD88 in Diminished Tumor Necrosis Factor Alpha Production by Newborn Mononuclear Cells in Response to Lipopolysaccharide , 2004, Infection and Immunity.

[20]  E. A. El-Harith.  The cytokine TNF-alpha. Genetics and suitability for prenatal risks assessment. , 2004, Saudi medical journal.

[21]  S. Akira,et al.  Regulation of dendritic cell function through toll-like receptors. , 2003, Current molecular medicine.

[22]  M. Goldman,et al.  Impaired responses to toll-like receptor 4 and toll-like receptor 3 ligands in human cord blood. , 2003, Journal of autoimmunity.

[23]  S. Akira,et al.  The Toll‐like receptor 7 (TLR7)‐specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily , 2003, European journal of immunology.

[24]  T. Wirth,et al.  Bruton's Tyrosine Kinase Is a Toll/Interleukin-1 Receptor Domain-binding Protein That Participates in Nuclear Factor κB Activation by Toll-like Receptor 4* , 2003, Journal of Biological Chemistry.

[25]  D. Persing,et al.  Enhancement of antigen-specific immunity via the TLR4 ligands MPL™ adjuvant and Ribi.529 , 2003, Expert review of vaccines.

[26]  T. Wirth,et al.  Bruton's tyrosine kinase is a Toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor kappaB activation by Toll-like receptor 4. , 2003, The Journal of biological chemistry.

[27]  H. Wagner,et al.  Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848 , 2002, Nature Immunology.

[28]  T. Giese,et al.  Quantitative Expression of Toll-Like Receptor 1–10 mRNA in Cellular Subsets of Human Peripheral Blood Mononuclear Cells and Sensitivity to CpG Oligodeoxynucleotides1 , 2002, The Journal of Immunology.

[29]  S. Akira,et al.  Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway , 2002, Nature Immunology.

[30]  C. Janeway,et al.  Innate immune recognition. , 2002, Annual review of immunology.

[31]  A. Omu,et al.  Th1 and Th2 cytokine profiles in recurrent aborters with successful pregnancy and with subsequent abortions. , 2001, Human reproduction.

[32]  M. Neurath,et al.  Regulation of IL-12 p40 Promoter Activity in Primary Human Monocytes: Roles of NF-κB, CCAAT/Enhancer-Binding Protein β, and PU.1 and Identification of a Novel Repressor Element (GA-12) That Responds to IL-4 and Prostaglandin E21 , 2001, The Journal of Immunology.

[33]  C. Galanos,et al.  MALP-2, a Mycoplasma lipopeptide with classical endotoxic properties: end of an era of LPS monopoly? , 2000, Journal of endotoxin research.

[34]  B. Beutler,et al.  Three novel mammalian toll-like receptors: gene structure, expression, and evolution. , 2000, European cytokine network.

[35]  R. Ulevitch,et al.  Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9. , 2000, European cytokine network.

[36]  Jiahuai Han,et al.  Regulation of TNF Expression by Multiple Mitogen-Activated Protein Kinase Pathways1 , 2000, The Journal of Immunology.

[37]  B. Adkins.  Development of Neonatal Th1/Th2 Function , 2000, International reviews of immunology.

[38]  C Caux,et al.  Immunobiology of dendritic cells. , 2000, Annual review of immunology.

[39]  M. Newport,et al.  Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guérin vaccination. , 1999, Journal of immunology.

[40]  R. Steinman,et al.  Myeloid dendritic cells , 1999, Journal of leukocyte biology.

[41]  J. Tappero,et al.  Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile. , 1999, JAMA.

[42]  D. Kwiatkowski,et al.  Similarities and differences between human and murine TNF promoters in their response to lipopolysaccharide. , 1999, Journal of immunology.

[43]  S. Akira,et al.  Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. , 1999, Journal of immunology.

[44]  R. Flavell,et al.  CD40 and CD154 in cell-mediated immunity. , 1998, Annual review of immunology.

[45]  Lambert Ph.  Vaccines for the world: major challenges for the future. , 1997 .

[46]  P. Lambert.  Vaccines for the world: major challenges for the future. , 1997, The Southeast Asian journal of tropical medicine and public health.

[47]  J. Silver,et al.  CD14-independent responses to LPS require a serum factor that is absent from neonates. , 1995, Journal of immunology.

[48]  T. Martin,et al.  Effects of endotoxin in the lungs of neonatal rats: age-dependent impairment of the inflammatory response. , 1995, The Journal of infectious diseases.

[49]  F. Fawthrop.  Inflammation: Basic Principles and Clinical Correlates , 1993 .

[50]  John I. Gallin,et al.  Inflammation: Basic Principles and Clinical Correlates , 1992 .

[51]  J. Klein,et al.  Infectious Diseases of the Fetus and Newborn Infant , 1983 .

[52]  T. L. Gerber,et al.  Health report , 1977, IMRE.

[53]  Health Report. , 1960, California medicine.